Transcription of PDA Draft Technical Report No. 29 - Pharmanet
{{id}} {{{paragraph}}}
Example: dental hygienist
PDA Draft Technical Report No. 29 - Pharmanet
PDA Technical Report No. 29 Points to Consider forCleaning ValidationDRAFTM arch 30, Pharmaceutical Cleaning validation Task ForceJames P. Agalloco, Agalloco & AssociatesWill Brame, Rhone-Poulenc RorerBohdan Ferenc, Novartis Pharmaceuticals E. Hall, , Hall & AssociatesKevin Jenkins, Pharmacia & Uphohn, T. LaMagna, Pfizer, E. Madsen, PDA (Chairman)Michael V. Mullen, , Eli Lilly and CompanyDietmar Wagenknecht, Fujisawa USA, M. Wagner, , Wyeth-Lederle Vaccines & PediatricsiiPrefaceThis document provides guidance relative to the validation of cleaning for a broad range of processingsystems and product types within the pharmaceutical industry. This effort commenced in 1991 inconjunction with individuals representing the biotechnology community.
ii Preface This document provides guidance relative to the validation of cleaning for a broad range of processing systems and product types within the pharmaceutical industry.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Strategic Considerations for ffoorr for Successful, Strategic Considerations for ffoorr for Successful Analytical Method, Analytical Method, Validation, GUIDELINES ON VALIDATION APPENDIX 4 ANALYTICAL, In early, 2016) 3 DRAFT FOR COMMENTS, World Health, Analytical, Dissolution Method Development for Immediate Release, Early, Analytical Methods And Techniques Applied, Method, Jianmei Kochling